Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Repros to drop testosterone drug in U.S. if key study fails
Repros to drop testosterone drug in U.S. if key study fails
Repros to drop testosterone drug in U.S. if key study fails
Submitted by
admin
on April 14, 2016 - 4:43pm
Source:
Yahoo/Reuters
News Tags:
Repros
testosterone
FDA
clinical trials
Androxal
uterine fibroids
Proellex
Headline:
Repros to drop testosterone drug in U.S. if key study fails
Do Not Allow Advertisers to Use My Personal information
